LNDC Stock Price, News & Analysis
Company Description
LNDC (NASDAQ: LNDC) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $259.3M.
LNDC stock has declined 8.2% over the past year.
This page provides a comprehensive overview of LNDC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
LNDC (LNDC) stock. Over the past 12 months, the stock has lost 8.2%. At a market capitalization of $259.3M, LNDC is classified as a micro-cap stock with approximately 29.6M shares outstanding.
Latest News
LNDC has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include partnership, conferences, earnings. View all LNDC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
LNDC Company Profile & Sector Positioning
LNDC (LNDC) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing LNDC often look at related companies in the same sector, including (MNKPF), Lifecore Biomedical Inc (LFCR), Aurora Cannabis Inc (ACB), Alpha Teknova (TKNO), and Organigram Global Inc (OGI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LNDC's relative position within its industry.